Inpharmatis

Merry Christmas and a Happy New Year! 🎄

As we approach the New Year, we sincerely thank our Clients and Partners for your trust and collaboration.

For Inpharmatis, this year has been both challenging and full of new opportunities. We welcomed reliable new Partners, expanded our service geography and entered new markets, strengthened our Team.

We enter 2026 with ambitious plans and clear goals, ready to support our Clients in achieving continued success and growth.

Wishing you joy, good health, and prosperity in the upcoming 2026 Year from the Inpharmatis Team! 🎉

📌 released the updated , outlining detailed procedures for to modify and update their . These new guidelines aim to enhance the lifecycle management of medicines by aligning with scientific and technological progress.

🌐 Read the detailed expert overview on our website - https://inpharmatis.com/eu-commission-announces-new-measures-to-improve-lifecycle-management-of-medicine-authorisations/

Inpharmatis is an expert in medicines registration across the , & . If you’d like to learn how we can support your regulatory needs, contact us at [email protected] 📨